Latest Innovation News

FirstWave’s Q4 FY25 update reveals a slight revenue decline but highlights a strategic AWS partnership and new chairman appointment, signaling a pivotal growth phase.

FBR Limited has locked in a A$20 million share subscription facility with GEM Global Yield LLC, providing flexible capital to advance its innovative robotics platforms and commercialisation efforts.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.

After four years on Colorado’s I-70 Vail Pass, EdenCrete® concrete shows markedly superior durability compared to standard and silica fume mixes, signaling a potential shift in high-altitude road construction.

News Corporation reported a robust fiscal 2025 with revenues climbing 2% to $8.45 billion and net income from continuing operations surging 71%. The company also announced a new $1 billion accelerated stock repurchase program, underscoring confidence in its financial strength.

Nanoveu Limited advances its proprietary 16nm ECS-DoT chip fabrication, targeting completion by Q4 2025, supported by a strategic partnership and expanded engineering teams across multiple continents.

Adisyn Ltd has initiated a pivotal phase in its graphene interconnect technology development, commissioning a state-of-the-art Atomic Layer Deposition system and collaborating globally to tackle semiconductor bottlenecks.

REA Group Ltd reported a robust FY25 with 15% revenue growth to $1.673 billion and a 23% rise in net profit, driven by strong Australian market performance and strategic AI investments. The company also advanced its India operations, focusing on Housing.com amid PropTiger divestment plans.

REA Group has reported a robust FY25 with strong revenue and profit growth, underpinned by solid Australian market performance and strategic moves in India. The company also announced a leadership transition amid optimistic FY26 guidance.

REA Group Ltd has reported robust FY25 results with a 15% increase in revenue and a 23% rise in core net profit, alongside a 31% lift in dividends. The company also announced the retirement of CEO Owen Wilson after a decade at the helm.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

Zoono Group Limited has closed its recent rights issue, raising $785,000 with a significant shortfall remaining. Managing Director Paul Hyslop fully subscribed and may provide further financial support as the company targets growth in Asia and product innovation.